anti-MT1-MMP antibody (iTherapeutics)

N/A

Report date: 2025/03/18 18:02:07

Base Information

Drug Nameanti-MT1-MMP antibody (iTherapeutics)
Drug Alias NameRNAi-therapy (iTherapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMatrix metalloproteinase-1 inhibitors
TargetsMatrix metalloproteinase-1
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiTherapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesiTherapeutics Corp
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A